- Patent Title: Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
-
Application No.: US15892409Application Date: 2018-02-08
-
Publication No.: US10677786B2Publication Date: 2020-06-09
- Inventor: Brett E. Crawford , Jillian R. Brown , Charles A. Glass , Jim R. Beitel , Robin M. Jackman
- Applicant: BIOMARIN PHARMACEUTICAL INC.
- Applicant Address: US CA Novato
- Assignee: BIOMARIN PHARMACEUTICAL INC.
- Current Assignee: BIOMARIN PHARMACEUTICAL INC.
- Current Assignee Address: US CA Novato
- Agency: Jones Day
- Main IPC: C12Q1/42
- IPC: C12Q1/42 ; G01N33/53 ; C12Q1/34 ; C12Q1/40 ; G01N33/68 ; C12Q1/527
Abstract:
Provided herein are methods of diagnosing or monitoring the treatment of mucopolysaccharidosis (MPS) I or a disorder associated with MPS I.
Public/Granted literature
Information query
